Evaluation of the Bioavailability of Pramlintide
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | June 2002 |
| End Date: | December 2002 |
This is a randomized, open-label, crossover study to examine the bioavailability of
pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes
mellitus using insulin.
pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes
mellitus using insulin.
Inclusion Criteria:
- HbA1c value between 6-12%
- BMI <= 27 kg/m2 or BMI >=30 to <= 45 kg/m2
- Consistent insulin regimen for 2 months prior to screening
We found this trial at
4
sites
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
Orlando, Florida 32806
407-240-7878
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials